STF-1019(STF-1019) - 在研适应症：肠道病毒感染_专利_临床

概要

基本信息

药物类型

小分子化药

别名

靶点-

作用方式-

作用机制-

治疗领域

感染

在研适应症

肠道病毒感染

非在研适应症-

原研机构

Stanford University

在研机构

Stanford University

Utah State University

非在研机构-

最高研发阶段临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 STF-1019 相关的临床结果

登录后查看更多信息

100 项与 STF-1019 相关的转化医学

登录后查看更多信息

100 项与 STF-1019 相关的专利（医药）

登录后查看更多信息

1

项与 STF-1019 相关的文献（医药）

2018-10-01·Antiviral Research

Meeting report: 31st International Conference on Antiviral Research

作者: Carter, Kara ; Bray, Mike ; Durantel, David ; Janeba, Zlatko ; Ballana, Ester ; Gentry, Brian ; Esté, José A ; Tarbet, Bart ; Andrei, Graciela ; Moffat, Jennifer ; Oomen, Clasien J ; Riveira-Muñoz, Eva

The 31^st International Conference on Antiviral Research (ICAR) was held in Porto, Portugal from June 11-15, 2018. In this report, volunteer rapporteurs provide their summaries of scientific presentations, hoping to effectively convey the speakers' goals and the results and conclusions of their talks. This report provides an overview of the invited keynote and award lectures and highlights of short oral presentations, from the perspective of experts in antiviral research. Of note, a session on human cytomegalovirus included an update on the introduction to the clinic of letermovir for the prevention of CMV infection and disease. The 31^st ICAR successfully promoted new discoveries in antiviral research and drug development. The 32^nd ICAR will be held in Baltimore, Maryland, USA, May 6-10, 2019.

100 项与 STF-1019 相关的药物交易

登录后查看更多信息